EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

Carrier‐Free Berberine/Nitidine Chloride Self‐Assembled Nanoparticles Induce Ferroptosis to Overcome Bortezomib Resistance in Multiple Myeloma

Yiwen Lv iD, Shuang Liu iD, Hong Wu, Guiluan Li, Ying Rong, Guangchao Li, Yangmin Zhu, Qi Zhong, Ruiming Ou, Huijuan Shen, Zhi Liu, Jing Huang iD and 5 more

Advanced Science · 2026-11 · 13 (62)

DOI: 10.1002/advs.77174 ↗

At a glance

Journal article in Advanced Science, published online on 2026-08-18. Written by Yiwen Lv and 16 co-authors. Institution: The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, People's Republic of China. Major MEDLINE topics: Ferroptosis, Berberine, Multiple Myeloma, Bortezomib. 44 references. The full text is freely available (open access, CC BY 4.0). Funded by: Guangzhou Science and Technology Plan Project, Foundation of Guangdong Second Provincial General Hospital, Guangdong Basic and Applied Basic Research Foundation.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Therapeutic relapse driven by bortezomib resistance represents a formidable clinical barrier in the management of multiple myeloma (MM). Here, a carrier‐free, supramolecular nanoplatform was engineered through the spontaneous co‐assembly of two natural alkaloids, berberine (BBR) and nitidine chloride (NC), termed BBR/NC‐SAPs, to counter this malignancy. Driven by cooperative π‐π stacking and van der Waals forces, BBR/NC‐SAPs display superior anti‐MM efficacy and optimized biosafety as compared to the free‐drug combination. Quantitative proteomics and functional landscapes showed that BBR/NC‐SAPs robustly activate iron‐dependent ferroptosis, as evidenced by massive lipid peroxidation, intracellular Fe 2+ overload, and mitochondrial depolarization. Mechanistically, integrated target deconvolution and atomistic molecular modeling identified NR2F2 as a direct target of BBR/NC‐SAPs. Functional knock‐out and rescue evaluations definitively validated that NR2F2 is an essential mediator governing the therapeutic response, as NR2F2 depletion occluded the ferroptotic cascade, and lentiviral reconstitution fully restored cellular sensitivity and GPX4‐associated ferroptosis activation. Further, BBR/NC‐SAPs markedly suppressed tumor growth and prolonged survival in bortezomib‐resistant MM xenograft models, a therapeutic benefit actively reversed by the ferroptosis inhibitor ferrostatin‐1. Collectively, this work highlights a paradigm of natural product‐derived nanotechnology that targets the NR2F2–GPX4 axis, offering a promising supramolecular strategy to overcome drug resistance in refractory hematological tumors.

Subjects

MeSH terms (MEDLINE)

FerroptosisBerberineMultiple MyelomaBortezomibDrug Resistance, NeoplasmNanoparticlesBenzophenanthridinesHumansAnimalsMiceCell Line, TumorAntineoplastic Agents

Author keywords

bortezomib resistancecarrier‐free self‐assemblyferroptosismultiple myelomanatural products

Substances

BerberineBortezomibBenzophenanthridinesnitidineAntineoplastic Agents

Authors and institutions

  • The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, People's Republic of China.
  • The Affiliated Guangdong Second Provincial General Hospital of Jinan University, Guangzhou, Guangdong, People's Republic of China.
  • Key Laboratory of Regenerative Medicine of Ministry of Education, Guangzhou, Guangdong, People's Republic of China.
  • Guangdong Province Key Laboratory of Pharmacodynamic Constituents of TCM and New Drugs Research, College of Pharmacy, Jinan University, Guangzhou, People's Republic of China.

ORCID profiles: Yiwen Lv, Shuang Liu, Jing Huang, Pei Lin, Qing Zhang, Guopan Yu, Zhao Yin

Funding

  • Guangzhou Science and Technology Plan Project
  • Foundation of Guangdong Second Provincial General Hospital
  • Guangdong Basic and Applied Basic Research Foundation
  • Traditional Chinese Medicine of Guangdong Province
  • Guangdong Medical Science and Technology Research
  • Basic and Applied Basic Research Foundation of Guangdong Province

Cite

APA

Lv, Y., Liu, S., Wu, H., Li, G., Rong, Y., Li, G., Zhu, Y., Zhong, Q., Ou, R., Shen, H., Liu, Z., Huang, J., Wang, Z., Lin, P., Zhang, Q., Yu, G., & Yin, Z. (2026). Carrier‐Free Berberine/Nitidine Chloride Self‐Assembled Nanoparticles Induce Ferroptosis to Overcome Bortezomib Resistance in Multiple Myeloma. Advanced Science, 13(62). https://doi.org/10.1002/advs.77174

Vancouver

Lv Y, Liu S, Wu H, Li G, Rong Y, Li G, et al. Carrier‐Free Berberine/Nitidine Chloride Self‐Assembled Nanoparticles Induce Ferroptosis to Overcome Bortezomib Resistance in Multiple Myeloma. Advanced Science. 2026;13(62). doi:10.1002/advs.77174

BibTeX
@article{Lv2026,
  author = {Lv, Yiwen and Liu, Shuang and Wu, Hong and Li, Guiluan and Rong, Ying and Li, Guangchao and Zhu, Yangmin and Zhong, Qi and Ou, Ruiming and Shen, Huijuan and Liu, Zhi and Huang, Jing and Wang, Zhenwei and Lin, Pei and Zhang, Qing and Yu, Guopan and Yin, Zhao},
  title = {Carrier‐Free Berberine/Nitidine Chloride Self‐Assembled Nanoparticles Induce Ferroptosis to Overcome Bortezomib Resistance in Multiple Myeloma},
  journal = {Advanced Science},
  year = {2026},
  volume = {13},
  number = {62},
  doi = {10.1002/advs.77174}
}
Start for free →